Cory Kasimov
Stock Analyst at Evercore ISI
(4.85)
# 379
Out of 4,453 analysts
986
Total ratings
57.7%
Success rate
17.4%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $50 | $27.72 | +80.38% | 1 | May 26, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $57.35 | +109.24% | 83 | May 21, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $200 → $210 | $164.18 | +27.91% | 16 | May 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $875 → $825 | $620.14 | +33.03% | 77 | May 18, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 | $19.40 | +106.19% | 7 | May 13, 2026 | |
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $25 | $13.00 | +92.31% | 1 | May 12, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $55 → $80 | $56.78 | +40.89% | 6 | May 8, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $65 | $53.79 | +20.84% | 1 | May 8, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $125 → $130 | $69.69 | +86.54% | 19 | May 8, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $35 → $45 | $33.93 | +32.63% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $41.69 | +7.94% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $9.88 | +82.19% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $178.17 | +12.25% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $530 → $535 | $480.18 | +11.42% | 59 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $50 | $59.75 | -16.32% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $293.17 | +36.44% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $14.18 | +139.77% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $80.80 | -0.99% | 10 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $9.46 | +164.27% | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $6.36 | +135.85% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $24.67 | +122.94% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $90.00 | +44.44% | 31 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $128 | $29.25 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $84 | $15.05 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $52.83 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $221 | $201.96 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $23.72 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $3.26 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $2.06 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $19 → $16 | $2.74 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $227 | $352.82 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $98 → $86 | $107.53 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $28.43 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $20.19 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $123.84 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $7.67 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $84.74 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $49.18 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.5597 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.93 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $100 | $1,127.69 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283.99 | $7.49 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.07 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $9.46 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $8.56 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $68 | $78.34 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $335.12 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $9.90 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $36.99 | n/a | 1 | Jun 4, 2013 |
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $27.72
Upside: +80.38%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $57.35
Upside: +109.24%
Neurocrine Biosciences
May 18, 2026
Maintained: Buy
Price Target: $200 → $210
Current: $164.18
Upside: +27.91%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $875 → $825
Current: $620.14
Upside: +33.03%
Immunome
May 13, 2026
Maintained: Buy
Price Target: $40
Current: $19.40
Upside: +106.19%
Benitec Biopharma
May 12, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $13.00
Upside: +92.31%
Xenon Pharmaceuticals
May 8, 2026
Maintained: Buy
Price Target: $55 → $80
Current: $56.78
Upside: +40.89%
Scholar Rock Holding
May 8, 2026
Maintained: Buy
Price Target: $65
Current: $53.79
Upside: +20.84%
BridgeBio Pharma
May 8, 2026
Maintained: Buy
Price Target: $125 → $130
Current: $69.69
Upside: +86.54%
Beam Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $35 → $45
Current: $33.93
Upside: +32.63%
May 8, 2026
Maintained: Buy
Price Target: $45
Current: $41.69
Upside: +7.94%
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $9.88
Upside: +82.19%
May 7, 2026
Maintained: Buy
Price Target: $200
Current: $178.17
Upside: +12.25%
May 5, 2026
Maintained: Buy
Price Target: $530 → $535
Current: $480.18
Upside: +11.42%
May 4, 2026
Maintained: Hold
Price Target: $35 → $50
Current: $59.75
Upside: -16.32%
May 1, 2026
Reiterated: Buy
Price Target: $400
Current: $293.17
Upside: +36.44%
May 1, 2026
Maintained: Buy
Price Target: $34
Current: $14.18
Upside: +139.77%
Apr 1, 2026
Maintained: Buy
Price Target: $80
Current: $80.80
Upside: -0.99%
Apr 1, 2026
Maintained: Buy
Price Target: $25
Current: $9.46
Upside: +164.27%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $6.36
Upside: +135.85%
Mar 17, 2026
Maintained: Buy
Price Target: $55
Current: $24.67
Upside: +122.94%
Mar 11, 2026
Maintained: Buy
Price Target: $130
Current: $90.00
Upside: +44.44%
Jul 29, 2022
Maintained: Buy
Price Target: $126 → $128
Current: $29.25
Upside: n/a
Jul 28, 2022
Maintained: Hold
Price Target: $91 → $84
Current: $15.05
Upside: n/a
Jul 27, 2022
Maintained: Hold
Price Target: $30 → $33
Current: $52.83
Upside: n/a
Jul 20, 2022
Maintained: Hold
Price Target: $219 → $221
Current: $201.96
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $23.72
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $14 → $11
Current: $3.26
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $24 → $20
Current: $2.06
Upside: n/a
May 4, 2022
Maintained: Sell
Price Target: $19 → $16
Current: $2.74
Upside: n/a
Apr 28, 2022
Maintained: Hold
Price Target: $235 → $227
Current: $352.82
Upside: n/a
Feb 9, 2022
Maintained: Hold
Price Target: $98 → $86
Current: $107.53
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $61
Current: $28.43
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $20.19
Upside: n/a
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $123.84
Upside: n/a
Feb 25, 2021
Maintained: Sell
Price Target: n/a
Current: $7.67
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $84.74
Upside: n/a
Nov 13, 2019
Maintained: Buy
Price Target: n/a
Current: $49.18
Upside: n/a
Jun 26, 2018
Maintained: Sell
Price Target: n/a
Current: $0.5597
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.93
Upside: n/a
Apr 11, 2017
Maintained: Buy
Price Target: $384 → $100
Current: $1,127.69
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $283.99
Current: $7.49
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $2.07
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $9.46
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $8.56
Upside: n/a
Jun 8, 2015
Maintained: Hold
Price Target: $65 → $68
Current: $78.34
Upside: n/a
Jan 13, 2015
Maintained: Hold
Price Target: n/a
Current: $335.12
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $9.90
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $36.99
Upside: n/a